EFX:NYSEEquifax, Inc. Analysis

Equifax is trading at $196.58, just below its 20‑day SMA of $199.70 and well under the 200‑day SMA of $231.70, indicating a short‑term bearish bias while the MACD histogram remains positive, suggesting lingering upside momentum. The RSI sits at 44, offering room for price recovery before hitting overbought levels, and the stock is perched near the technical support of $185.61 with resistance around $211.12. Volatility is elevated at roughly 55% over the past 30 days and beta exceeds 1, reflecting higher sensitivity to market swings, while volume trends are decreasing, hinting at waning short‑term participation. Fundamentally, revenue grew 9.2% YoY to $6.07 B, margins are solid (gross 56%, operating 18%), and free cash flow exceeds $1 B, supporting a sustainable dividend yield of 1.01% with a payout ratio near 35%. However, the balance sheet is leveraged—debt‑to‑equity tops 110% and total debt dwarfs cash holdings—raising concerns about financial flexibility. Analysts are optimistic, assigning a “Buy” consensus, a median price target of $240 and noting a recent 12% dividend increase alongside a BofA upgrade. The juxtaposition of a technically bearish chart, strong cash generation, and upbeat analyst sentiment creates a nuanced outlook: short‑term caution but medium‑term upside potential. Key drivers include earnings acceleration (forward EPS $10.36), dividend uplift, and expanding Workforce Solutions revenue, while headwinds stem from regulatory scrutiny in data privacy and high leverage. Overall, the stock appears poised for a modest rebound if it can break above the $211 resistance, but investors should monitor debt service metrics and volatility.